Drug-Eluting Balloon Catheters Market Growing from 2025 to 2031 |...

Drug-Eluting Balloon Catheters Market Growing from 2025 to 2031

Posted 2026-02-06 17:05:03

18K

Market Overview

The Drug-Eluting Balloon (DEB) Catheters Market consists of interventional medical devices that use balloon catheters with pharmacological agents such as anti-proliferative drugs to treat blood vessel blockages and narrowing. These catheters serve as primary tools for angioplasty procedures when treating patients who have coronary artery disease (CAD) and peripheral artery disease (PAD). The drug-eluting balloon catheter provides medication delivery to arterial walls during inflation which minimizes restenosis risk while eliminating the need for permanent implantation. The market experiences growing demand because these devices effectively treat complex lesions and small vessels and in-stent restenosis while providing minimal invasiveness. Key Players

Medtronic, Boston Scientific Corporation, Cook Medical, B Braun Melsungen AG, Terumo Corporation, Becton Dickinson and Company, Biotronik, Spectranetics Philips, Cardinal Health, Koninklijke Philips NV, Cordis Cardinal Health, MicroPort Scientific Corporation, iVascular, Hexacath, QT Vascular, Acrostak, Cardionovum, Concept Medical, MedAlliance, Biotronik, Surmodics, Aachen Resonance, iVascular, iVascular

Sample link - https://www.trendbridgeinsights.com/industry-report/drug-eluting-balloon-catheters-market

Market segmentation:

Product Type

· Peripheral Drugeluting Balloon Catheters

· Coronary Drugeluting Balloon Catheters

· Urology Drugeluting Balloon Catheters

· Neurovascular Drugeluting Balloon Catheters

Coating Material

· Paclitaxelcoated Drugeluting Balloon Catheters

· Sirolimuscoated Drugeluting Balloon Catheters

· Zotarolimuscoated Drugeluting Balloon Catheters

· Others

Application

· Coronary Artery Disease

· Peripheral Artery Disease

· Urological Disorders

· Neurovascular Diseases

End User

· Hospitals

· Ambulatory Surgical Centers

· Specialty Clinics

· Others

Mega Trend Connect:

This report offers deep insights into how mega trends such as digitalization, precision medicine, data-driven care delivery, and regulatory evolution are transforming medical devices. It further examines the impact of advanced technologies, platform-based models, automation, and interoperability across products and services within this segment. The report assesses regulatory complexity, adoption readiness, cost pressures, and ecosystem maturity shaping global market development.

Global Trade Outlook:

Global trade in medical devices is increasingly shaped by regulatory stringency, localization mandates, data sovereignty requirements, and public health policy priorities. Cross-border scalability is constrained by approval timelines, compliance variation, and infrastructure readiness, driving regionalized production, partnerships, and delivery models. Market access and competitiveness now depend on regulatory agility, localized execution, and compliance-by-design strategies.

Region Analysis :

Europe leads drug-eluting balloon catheter production due to advanced manufacturing hubs in Germany, Switzerland, and Ireland, strong R&D, and supportive regulations. North America drives demand through minimally invasive procedures and reimbursement support. Asia-Pacific shows rapid growth in manufacturing, while Latin America and MEA mainly rely on imports.

Recent development :

In March 2025,Medtronic plc obtained CE Mark approval for its new drug-coated balloon In.Pact AV which targets arteriovenous fistula (AVF) maintenance for dialysis patients. The product uses proprietary drug-delivery technology to extend vessel patency while decreasing the need for repeated interventions.

FAQ:

1 . What is the Forecasted market size & CAGR of the Drug-eluting Balloon Catheters Market ?

The global Drug-Eluting Balloon Catheters Market reached USD 745 million in 2023 and experts predict it will expand at an 8.7% CAGR to reach USD 810 million in 2024 and USD 1.23 billion by 2029.

2. Who are the leading manufacturers and suppliers in the Drug-eluting Balloon Catheters Market ?

3. What are the upcoming trends of Drug-eluting Balloon Catheters Market in the globe?

Advanced Drug Coating Technologies: Advanced drug formulations combined with enhanced coating methods result in improved drug retention and controlled drug release during catheter deployment. The combination of antiproliferative drugs paclitaxel and sirolimus delivers enhanced restenosis prevention with decreased systemic side effects.

4. Which is the largest regional market for Drug-eluting Balloon Catheters Market ?

Europe stands as the leading producer in the drug-eluting balloon catheters market. The drug-eluting balloon catheters market benefits from European production rates because the region hosts globally recognized medical device manufacturers who operate in Germany Switzerland and Ireland.

About US: